75900-95-7Relevant articles and documents
In silico design of HDAC6 inhibitors with neuroprotective effects
Bello, Martiniano,de Pedro, Nuria,Correa-Basurto, José,Gómez-Vidal, José Antonio,Rosales-Hernández, Martha Cecilia,Sixto-López, Yudibeth
, (2021/11/24)
HDAC6 has emerged as a molecular target to treat neurodegenerative disorders, due to its participation in protein aggregate degradation, oxidative stress process, mitochondrial transport, and axonal transport. Thus, in this work we have designed a set of
